Award Recipients

Excellence In Research Awards

The 2019 ASGCT Excellence in Research Awards were presented on Tuesday, April 30 during the George Stamatoyannopoulos Memorial Lecture to the following researchers:

Filippo Birocchi San Raffaele Telethon Institute for Gene Therapy	Allison Bradbury, Ph.D. University of Pennsylvania	Alessio Cantore, Ph.D. San Raffaele Telethon Institute for Gene Therapy	Daniela Cesana San Raffaele Telethon Institute for Gene Therapy
Amanda Dudek, Ph.D. Grousbeck Gene Therapy Center, Mass Eye and Ear, Harvard Medical School	Samuel Huang Oregon Health and Science University	Hak Kyun Kim, DPhil Stanford University	Chang Li, Ph.D. University of  Washington
Richard Morgan University of California, Los Angeles	Christopher Nelson, Ph.D. Duke University	Giulia Pavani, Ph.D. Genethon	Afrooz Rashnonejad, Ph.D. Nationwide Children's Hospital
Dimah Saade, Ph.D. NINDS, NIH	Giulia Schiroli, Ph.D. San Raffaele Telethon Institute for Gene Therapy	Meredith Sosulski, Ph.D. Weill Cornell Medical College	Anne Vonada Oregon Health and Science University

The 2019 Excellence in Research Awards are made possible by the generous sponsorship of:

Travel Awards

The 2019 ASGCT Meritorious and Underrepresented Minority Travel Awards were presented during the respective presentations of the awardees at the 21st Annual Meeting:

Kaothara Adeyanju	Aisha AlJanahi	Filippo Birocchi	Daniel Bittel	Matthias Bozza
Allison Bradbury	Mariana Bravo-Hernandez	Mitchell Brun	John Butterfield	Suvd Byambaa
Alessio Cantore	Sean Carrig	Antonio Carusillo	Jessica Centa	Ana Cepeda Diaz
Daniela Cesana	Ying Kai Chan	Shyambabu Chaurasiya	Valery Chavez	Chun-Yu Chen
Beatrice Cianciotti	Pasqualina Colella	Julie Crudele	Alessia De Caneva	Joanne Marie Del Rosario
Nathan Delvaux	Peter Deng	Amanda Dudek	Corey Duke	Nicholas Economos
Chelsea Edelblute	Eric Ehrke-Schulz	Lauren Fleischer	Christos Georgiadis	Gwladys Gernoux
Trevor Gonzalez	Veronica Gough	Beatrice Greco	Amanda Gross	Julian Grünewald
Simone Hager	Mohamad Hamieh	Jiaying Han	L Havlik	Mareike Hoffmann
Samuel Huang	Raed Ibraheim	Julia Joo	Maja Kalbarczyk	Xi Kang
Hye Ri Kang	Megan Keiser	Hak Kyun Kim	Swapna Kollu	Biao Kuang
Elisa Landoni	Rachael Levings	Xinghuo Li	Chang Li	Telmo Llanga
Kevin Luk	Mirko Luoni	Victoria Madigan	Laura Marquez Loza	Rika Maruyama
R Mellen	Mario Mietzsch	Feiyan Mo	Leon Morales	Richard Morgan
Mustafa Munye	Kelsey Murphy	Christopher Nelson	Matthew Nitzahn	Ashlesha Odak
Nandakumar Packiriswamy	Helena Palau	Eleni Panagioti	Giulia Pavani	Christopher Petersen
Karl Petri	Anastasia Petrova	Benjamin Philipson	Adrian Pickar-Oliver	Alexandra Piotrowski-Daspit
Brooke Prinzing	Nikoleta Psatha	Elias Quijano	Shuquan Rao	Afrooz Rashnonejad
Steven Rheiner	Alicia Roig-Merino	Blake Rust	Dimah Saade	Andrew Satterlee
Giulia Schiroli	Sandhya Sharma	Jamie Shirley	Surya Shrivastava	Anze Smole
Laura Spector	Sabrina Sun	Takahiro Tadokoro	Toloo Taghian	Kazuhiro Takahama
Amita Tiyaboonchai	Patrizia Tornabene	Gabriela Toro Cabrera	Brian Truong	Mildred Unti
Valentina Vavassori	Monica Volpin	Anne Vonada	Hongjie Wang	Huawei Wang
Jiao Wang	Volker Wiebking	David Wilson	Meiyu Xu	Hua Yang
Hideki Yoshida	Carolyn Yrigollen	Mihaela Zabulica	Markella Zannikou	Xintao Zhang
Detu Zhu

The 2019 ASGCT Travel Awards are made possible by the generous support of the following sponsors:

2019 Outstanding Poster Award Winners

Basel T. Assaf—Pfizer Inc.
Preclinical Evaluation of an AAV-Based Gene Therapy Approach for the Treatment of Friedreich Ataxia Cardiomyopathy

Enrico R. Barrozo—University of Florida, Gainesville
AAV-Mediated Ribozyme Gene Therapy for Ocular Herpes

Camilo Breton—University of Pennsylvania
Meganuclease Suicide System, a Self-Inactivation Method to Reduce Nuclease Expression and Off-Target Activity

Jessika Ceiler—National Center for Tumor Diseases and German Cancer Research Center
Wild-Type and Recombinant AAV: Novel Insights into Mitochondrial Integration and Trafficking

ZeNan L. Chang—University of California, Los Angeles
Rewiring T-Cell Signaling Responses to Extracellular Soluble Cues with Chimeric Antigen Receptors

Eun-Young Choi—NICHD, NIH
AAV6-Mediated Choroid Plexus-Targeted Gene Therapy for Alpha-Mannosidosis

Rebecca Cooper—Biogen
Optimizing Residual DNA Detection for Gene Therapy Programs

Sarah Isabel Davies—National Heart, Lung, and Blood Institute
Merkel Cell Polyomavirus Oncoprotein-Specific T Cells Generated from Healthy Donors for Potential Adoptive Immunotherapy

Benjamin Deverman—Broad Institute of MIT and Harvard
Elucidating the Mechanism of Blood-Brain Barrier Transcytosis by the Engineered AAV-PHP.B Capsids: A Critical Step towards Developing AAV Capsids for Human Gene Therapy

Giacomo Frati—INSERM
Fetal Hemoglobin De-Repression Following CRISPR/Cas9 Mediated Targeting of the γ-Globin Promoters as a Therapeutic Strategy foR β-Hemoglobinopathies

Christopher D. Greer—University of Pennsylvania
Implications of Deep Evolutionary History of Locomotion for Muscular Dystrophy Transgene Design

Akihito Inagaki—University of California, San Francisco
Retroviral Replicating Vector-Mediated Prodrug Activator Gene Therapy with Engineered Human Mesenchymal Stem Cells in an Experimental Glioma Model

Lori B. Karpes—Voyager Therapeutics
Stability of rAAV Vectors: Response to Various Biochemical and Biophysical Stresses

Shiron J. Lee—University of Toronto
Developing Gene Therapy for Treating Intractable Epilepsy in Dravet Syndrome

Laura I. Marquez Loza—University of Iowa
Codon Optimization Enhances Functional Cystic Fibrosis Transmembrane Conductance Regulator Expression

Wren Michaels—Chicago Medical School, Rosalind Franklin University of Medicine and Science
Splice-Switching Antisense Oligonucleotides for the Treatment of Cystic Fibrosis

Leon Morales—University of Pennsylvania
Utrophin Vector Protected by Central Tolerance as Potential Cure for Muscular Dystrophy

Sara Regio—CHUV (Lausanne University Hospital)
A Single Vector Approach in the Self-Inactivating KamiCas9 System with a Viral-Mediated Retrograde Transport

Rebecca E. Ryan—Emory University
Optimizing Gamma Delta T Cells Expansion for Cell-Based Immunotherapies

Abdul Mohin Sajib—Auburn University
Precise Genetic Modification of Canine Adenovirus Type 2 (CAV2) Genome by CRISPR/CAS9

Nina Semenova—Old Dominion University
Cytoplasmic Nucleic Acids Sensing in Mouse Myoblasts after Plasmid DNA Transfection: Potential Involvement of Multiple Proteins

Tracey L. Smith—Rutgers New Jersey Medical School
Targeted AAVP-Based Therapy in a Mouse Model of Human Glioblastoma: A Comparison of Cytotoxic Versus Suicide Gene Delivery Strategies

Nolan D. Sutherland—bluebird bio
The Ambr 15 System as a Screening Tool for Lentiviral Vector Process Development

Manuela Urban—DNA Vectors, DKFZ
Utilising Non-Viral Episomal S/MAR DNA Vectors for the Persistent Genetic Modification of hiPSCs

Guan Wang—University of Southern California, Los Angeles
Immunodominant and Cryptic Tumor Neoantigen Specific Immune Responses Activated by an Armed Oncolytic Virus Expressing a PD-L1 Inhibitor

Elizabeth Weisman—Obsidian Therapeutics
Regulation of CD40L Transgene Expression in Human CAR-T Cells Using FDA Approved Ligands

Lane H. Wilson—University of Connecticut School of Medicine
Effects of PhK Deficiency in a Mouse Model of Glycogen Storage Disease Type IX